Showing 581-590 of 822 results for "".
Headache Horizons: Headache Pharmacology and Novel Therapeutics Update
https://practicalneurology.com/diseases-diagnoses/headache-pain/headache-horizonsbrheadache-pharmacology-and-novel-therapeutics-update/32118/Understanding the pharmacokinetics of recently introduced preventive treatments for headache can help the practitioner optimize migraine treatment.Neuromuscular Notes: Autoantibodies in Immune Myopathies
https://practicalneurology.com/diseases-diagnoses/neuromuscular/neuromuscular-notes-autoantibodies-inimmune-myopathies/31543/Antibody testing results provide clinically useful information.Postural Orthostatic Tachycardia Syndrome
https://practicalneurology.com/diseases-diagnoses/imaging-testing/postural-orthostatic-tachycardia-syndrome/31643/POTS is a cause of dizziness, fatigue, cognitive dysfunction, and headaches that can significantly contribute to poor quality of life.- Yielding to Epilepsy: Exploring Each State's “Rules of the Road”https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN0306DrivingFeature-pdf/31334/Navigating Driving Restrictions for Epilepsy Patients: Balancing Independence and Public SafetyRecent high-profile athletes like Alan Faneca and Chanda Gunn have highlighted that individuals with epilepsy can achieve remarkable successes when their seizures are well-controlled. However, for many epi
Real-World Experience Using Biomarker Testing for the Evaluation of Acute Traumatic Brain Injury
https://practicalneurology.com/diseases-diagnoses/tbi/real-world-experience-using-biomarker-testing-for-the-evaluation-of-acute-traumatic-brain-injury-1/32192/Integrating blood biomarker testing for traumatic brain injury into practice can help address some limitations with existing evaluative methods, leading to more timely and cost-effective diagnosis and improved health-related quality of life for affected individuals.Neuromuscular Notes: New and Emerging Therapies in ALS
https://practicalneurology.com/diseases-diagnoses/neuromuscular/neuromuscular-notes-new-and-emerging-therapies-in-als/32007/New therapies—including antisense oligonucleotides, mesenchymal stem cells, and kinase inhibitors—are in development to target specific pathogenic mechanisms identified in ALS.Real-World Experience Using Biomarker Testing for the Evaluation of Acute Traumatic Brain Injury
https://practicalneurology.com/diseases-diagnoses/imaging-testing/real-world-experience-using-biomarker-testing-for-the-evaluation-of-acute-traumatic-brain-injury/32184/Integrating blood biomarker testing for traumatic brain injury into practice can help address some limitations with existing evaluative methods, leading to more timely and cost-effective diagnosis and improved health-related quality of life for affected individuals.Dystrophinopathies and the Limb-Girdle Muscular Dystrophies
https://practicalneurology.com/diseases-diagnoses/neuromuscular/dystrophinopathies-and-the-limb-girdle-muscular-dystrophies/32028/Disease management for dystrophinopathies and limb-girdle muscular dystrophies has evolved from palliation to genetic therapeutics, paving the way toward a cure.Migraine Preventive Therapies
https://practicalneurology.com/diseases-diagnoses/headache-pain/migraine-preventive-therapies/31511/With new—and first-in-class—migraine-specific treatments, preventive treatment of migraine is changing quickly.Neural Antibodies as Diagnostic Biomarkers of Autoimmune Encephalitis and Inflammatory Demyelinating Disease
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/neural-antibodies-as-diagnostic-biomarkers-of-autoimmune-encephalitis-and-inflammatory-demyelinating-disease/32103/Neural antibodies are diagnostic biomarkers of autoimmune encephalitis, NMOSD, and MOGAD.